Table 3.

G fragment positions with variations in amino acid sequence. The changes with regard to the XJ13 strain are annotated in bold letters. Type 2 mutations among vaccine related strains are shadowed in gray. Adapted from [13]

Residue Position	XJ13	XJ17	XJ34	XJ39	XJ#44	XJ48	Candid#1	MC2	IV4454	Romero	AN_8640	AN_5185	AN_13365	AN_16501	AN_17058	AN_17246	AN_17116	AN_17064	H_Lye63	H_FHA5069	H_p1879	H_FHA5054	H_8027
107	S	S	S	S	S	S	S	S	T	S	S	S	S	S	S	S	S	S	S	T	T	T	S
109	Q	Q	Q	Q	Q	Q	Q	K	M	M	Q	Q	Q	M	Q	Q	M	M	Q	M	M	M	Q
111	S	S	S	S	S	S	S	S	T	S	S	S	S	S	T	S	S	S	S	T	T	T	S
116	A	A	A	A	A	A	A	A	A	E	A	A	A	A	A	A	A	A	A	A	A	A	A
121	Q	Q	Q	Q	Q	Q	Q	E	Q	Q	Q	Q	E	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q
125	I	I	I	I	I	I	I	I	V	I	I	I	I	I	V	I	I	I	I	V	V	V	I
133	S	S	S	S	S	S	S	S	S	S	S	S	S	N	S	S	N	N	S	S	S	S	S
143	W	W	W	W	W	W	W	W	W	W	W	W	W	W	W	W	W	W	W	R	R	R	W
151	A	A	A	A	A	A	A	A	A	A	A	A	A	A	A	A	A	A	A	V	V	V	A
157	H	H	H	H	H	H	H	Y	Y	H	H	H	H	H	H	H	H	H	H	H	H	H	H
168	T	A	A	A	A	A	A	T	T	T	A	A	T	T	A	A	T	T	A	T	T	T	A
184	V	V	V	V	V	V	V	I	V	V	V	V	V	V	V	V	V	V	V	V	V	V	V
186	E	E	E	E	E	E	G	E	E	E	G	G	E	E	G	G	E	E	G	E	E	E	G
206	S	S	S	S	S	S	P	S	S	S	P	P	S	S	P	P	S	S	P	S	S	S	P
208	P	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L
209	N	N	N	N	N	N	N	D	S	N	N	N	N	N	N	N	N	N	N	S	S	S	N
244	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	Q	H	Q
245	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	L	F	L